Cargando…

Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90)

BACKGROUND: Addiction is a relapsing chronic condition in which psychiatric phenomena play a crucial role. Psychopathological symptoms in patients with heroin addiction are generally considered to be part of the drug addict's personality, or else to be related to the presence of psychiatric com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maremmani, Icro, Pani, Pier Paolo, Pacini, Matteo, Bizzarri, Jacopo V, Trogu, Emanuela, Maremmani, Angelo GI, Gerra, Gilberto, Perugi, Giulio, Dell'Osso, Liliana
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Primary research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861658/ https://www.ncbi.nlm.nih.gov/pubmed/20388223 http://dx.doi.org/10.1186/1744-859X-9-15

Ejemplares similares

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry
por: Maremmani, Icro, et al.
Publicado: (2012)

Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?
por: Maremmani, Icro, et al.
Publicado: (2007)

Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug?
por: Pani, Pier Paolo, et al.
Publicado: (2016)

Correlations Between Awareness of Illness (Insight) and History of Addiction in Heroin-Addicted Patients
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2012)

Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment
por: Pani, Pier Paolo, et al.
Publicado: (2014)

The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients
por: Maremmani, Angelo G.I., et al.
Publicado: (2019)

Long-Term γ-Hydroxybutyric Acid (GHB) and Disulfiram Combination Therapy in GHB Treatment-Resistant Chronic Alcoholics
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Adult separation anxiety in patients with complicated grief versus healthy control subjects: relationships with lifetime depressive and hypomanic symptoms
por: Dell'Osso, Liliana, et al.
Publicado: (2011)

The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2016)

Delineating the Psychic Structure of Substance Use and Addictions, from Neurobiology to Clinical Implications: Ten Years Later
por: Pani, Pier Paolo, et al.
Publicado: (2020)

Can Ropinirole Modulate Reinforcing Subjective Effects of Cocaine in Humans?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

Symptomatological Features of Patients with and without Ecstasy Use during Their First Psychotic Episode
por: Rugani, Fabio, et al.
Publicado: (2012)

Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
por: Della Rocca, Filippo, et al.
Publicado: (2023)

The impact of psychopathological subtypes on retention rate of patients with substance use disorder entering residential therapeutic community treatment
por: Maremmani, Angelo G. I., et al.
Publicado: (2016)

Further Evidence of a Specific Psychopathology of Addiction. Differentiation from Other Psychiatric Psychopathological Dimensions (Such as Obesity)
por: Maremmani, Angelo G.I., et al.
Publicado: (2017)

The Conceptual Framework of Dual Disorders and Its Flaws
por: Pacini, Matteo, et al.
Publicado: (2020)

Six-Month Outcome in Bipolar Spectrum Alcoholics Treated with Acamprosate after Detoxification: A Retrospective Study
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2014)

Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner Syndrome
por: Quaranta, Giuseppe, et al.
Publicado: (2015)

Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD
por: Manni, Corrado, et al.
Publicado: (2019)

Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up
por: Maremmani, Angelo G. I., et al.
Publicado: (2021)

Erratum to: Agonist Opioid Treatment as historical comprehensive treatment (‘Dole & Nyswander’ methodology) is associated with better toxicology outcome than Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2017)

Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features
por: Spera, Vincenza, et al.
Publicado: (2020)

Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture?
por: Spera, Vincenza, et al.
Publicado: (2021)

Symptomatological Variants and Related Clinical Features in Adult Attention Deficit Hyperactive Disorder
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Exploring the Role of Caffeine Use in Adult-ADHD Symptom Severity of US Army Soldiers
por: Cipollone, Giada, et al.
Publicado: (2020)

Toward the Identification of a Specific Psychopathology of Substance Use Disorders
por: Maremmani, Angelo G. I., et al.
Publicado: (2017)

Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
por: Barbuti, Margherita, et al.
Publicado: (2023)

Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health
por: Lovrecic, Barbara, et al.
Publicado: (2019)

Psychiatric Symptoms in Patients with Cerebral Endometriosis: A Case Report and Literature Review
por: Elefante, Camilla, et al.
Publicado: (2022)

Psychiatric Aspects of Obesity: A Narrative Review of Pathophysiology and Psychopathology
por: Weiss, Francesco, et al.
Publicado: (2020)

Gender Differences in the Relationship between Maladaptive Behaviors and Post-Traumatic Stress Disorder. A Study on 900 L’ Aquila 2009 Earthquake Survivors
por: Dell’Osso, Liliana, et al.
Publicado: (2013)

Harm Reduction as “Continuum Care” in Alcohol Abuse Disorder
por: Maremmani, Icro, et al.
Publicado: (2015)

Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients
por: Fornaro, Michele, et al.
Publicado: (2011)

Development and validation of a stock addiction inventory (SAI)
por: Youn, HyunChul, et al.
Publicado: (2016)

Could Temperamental Features Modulate Participation in Clinical Trials?
por: Cintoli, Simona, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_niqdt66e8i35o6fj5tuk3a6ass